These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37085864)

  • 1. METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.
    Zhan L; Zhang J; Zhang JH; Liu XJ; Guo B; Chen JH; Tang ZH; Wang WY; Wang QY; Wei B; Cao YX
    Biomark Res; 2023 Apr; 11(1):43. PubMed ID: 37085864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRC5 potentiates anti-tumor CD8
    Zhang J; Guo B; Chen JH; Liu XJ; Zhang JH; Zhu HQ; Wang WY; Tang ZH; Wei B; Cao YX; Zhan L
    Transl Oncol; 2023 Oct; 36():101742. PubMed ID: 37531863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3-Mediated N6-Methyladenosine Modification of lncRNA D26496 Suppresses the Proliferation and Migration of Schwann Cells after Sciatic Nerve Injury.
    He X; Zhang J; Guo Y; Yang X; Huang Y; Hao D
    Mol Neurobiol; 2023 May; 60(5):2413-2425. PubMed ID: 36656457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
    Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
    Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1.
    Yang J; Fang M; Yu C; Li Z; Wang Q; Li C; Wu J; Fan R
    Ann Transl Med; 2023 Aug; 11(10):350. PubMed ID: 37675298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
    Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
    J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 Promotes OSCC Progression by Down-Regulating WEE1 in a m6A-YTHDF2-Dependent Manner.
    Su Y; Hu Y; Qu B; Lei R; Guo G
    Mol Biotechnol; 2024 May; ():. PubMed ID: 38744787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.
    Fan L; Wu J; Wang H; Chen Q; He X; Wang Q; Yang Z
    Ann Clin Lab Sci; 2022 Nov; 52(6):884-894. PubMed ID: 36564065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging.
    Wang Y; Chen Y; Xiao H; Liu Z; Liu X; Feng Z; Sheng X; Peng B; Ren X; Xu L; Teng F; Yi Z; Niu Y; Xiang D; Xia Y; Geng B
    Cell Death Discov; 2024 Mar; 10(1):155. PubMed ID: 38538596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
    Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q
    J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.
    Zhou D; Tang W; Xu Y; Xu Y; Xu B; Fu S; Wang Y; Chen F; Chen Y; Han Y; Wang G
    Mol Oncol; 2021 Aug; 15(8):2172-2184. PubMed ID: 33411363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.
    Wang X; Wang J; Zhao X; Wu H; Li J; Cheng Y; Guo Q; Cao X; Liang T; Sun L; Zhang G
    J Transl Med; 2023 Jun; 21(1):407. PubMed ID: 37353804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyltransferase-like 3 aggravates endoplasmic reticulum stress in preeclampsia by targeting TMBIM6 in YTHDF2-dependent manner.
    Chen Y; Liu X; Li L; He X; Zheng F; Zhang Y; Gao H; Jin Z; Wu D; Wang Q; Tao H; Zhao Y; Liu W; Zou L
    Mol Med; 2023 Feb; 29(1):19. PubMed ID: 36747144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-186-5p prevents hepatocellular carcinoma progression by targeting methyltransferase-like 3 that regulates m6A-mediated stabilization of follistatin-like 5.
    Ma S; Chen F; Lin C; Sun W; Wang D; Zhou S; Chang S; Lu Z; Zhang D
    Heliyon; 2024 Mar; 10(5):e26767. PubMed ID: 38463829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3/YTHDF2 m
    Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
    J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.